Emerging Infections Program

OMB Control No: 0920-0978	ICR Reference No: 202204-0920-008
Status: Received in OIRA	Previous ICR Reference No: 202112-0920-010
Agency/Subagency: HHS/CDC	Agency Tracking No: 0920-0978
Title: Emerging Infections Program
Type of Information Collection: Revision of a currently approved collection	Common Form ICR:  No
Type of Review Request: Regular	Date Submitted to OIRA: 04/25/2022

	Requested	Previously Approved
Expiration Date	36 Months From Approved	04/30/2022
Responses	132,520	99,360
Time Burden (Hours)	53,784	38,810
Cost Burden (Dollars)	0	0

---

Abstract: The Emerging Infections Programs (EIP) is to 1) detect and monitor emerging pathogens, the diseases they cause, and the factors influencing their emergence, and respond to problems as they are identified, 2) integrate laboratory science and epidemiology to optimize public health practice, 3) strengthen infrastructure to support surveillance and research and to implement prevention and control programs, and to 4) ensure implementation of prevention strategies and communication of public health information about emerging diseases. Surveillance efforts of the core EIP activities generate reliable estimates of the incidence of certain infections and provide the foundation for a variety of epidemiologic studies. This Revision requests the use of two additional forms and including minor revised language and rewording to improve clarity and readability of the data collection forms.

---

Authorizing Statute(s): US Code: 42 USC 301 Name of Law: Public Health Service Act

Citations for New Statutory Requirements: None

---

Associated Rulemaking Information
RIN:	Stage of Rulemaking:	Federal Register Citation:	Date:
	Not associated with rulemaking

---

Federal Register Notices & Comments
60-day Notice:	Federal Register Citation:	Citation Date:
	87 FR 4891	01/31/2022
30-day Notice:	Federal Register Citation:	Citation Date:
	87 FR 24305	04/25/2022
Did the Agency receive public comments on this ICR? No

---

Number of Information Collection (IC) in this ICR: 35

IC Title Form No. Form Name ABCs Case Report Form 0920-0978 2022 ABC Surveillance Case Report ABCs H. Influenzae Neonatal Sepsis Expanded Surveillance Form 0920-0978 ABC H. Influenzae Neonatal Sepsis Expanded Surveillance Form ABCs Invasive Pneumococcal Disease in Children 0920-0978 ABC Invasive Pneumococcal Disease in Children (age>2 months to <5 years ABCs Neonatal Infection Expanded Tracking Form none Neonatal Infection Expanded Tracking Form ABCs Severe GAS Infection Supplemental Form 0920-0978 ABC Severe GAS Infection Supplemental Form Community-Associated CP-CRE Interview 0920-0978 CA CP-CRE Survey Questionnaire Flu Surv NET Laboratory Survey none FluSurv Lab Survey FoodNet Campylobacter FoodNet Cyclospora FoodNet Hemolytic Uremic Syndrome (HUS) 0920-0978 FoodNet HUS CRF FoodNet Listeria monocytogenes FoodNet Salmonella FoodNet Shiga toxin producing E. coli FoodNet Shigella FoodNet Vibrio FoodNet Yersinia Foodnet Clinical Laboratory Practices and Testing Volume none FoodNET Lab Practices Volume HAIC CDI Annual Laboratory Survey n/a Annual Survey of Laboratory Testing Practices for C. difficile Infection HAIC CDI Annual Surveillance Officers Survey 0920-0978 Surveillance Officer's Survey HAIC CDI Case Report Form none CDI Case Report HAIC CDI LTCF Survey 0920-0978 Emerging Infections Progrom C. difficile Surveillance Nuring Home Telephone Call Survey HAIC Candidemia Case Report Form none Candidemia Case Report HAIC Candidemia Periodic Laboratory Survey none Candidemia Lab Survey HAIC Death Ascertainment Project 0920-0978 Death Ascertainment Project Variables HAIC Invasive Methicillin-Sensitive Staphylococcus aureus (MSSA) none MSSA Report 2021 HAIC Invasive Methicillin-resistant Staphylococcus aureus (MRSA) none Invasive MRSA Case Report HAIC Invasive Staphylococcus aureus Annual Laboratory Survey none Invasive Staph aureus Lab Survey HAIC Invasive Staphylococcus aureus Annual Surveillance Officers Survey 0920-0978 2019 HAIC Invasive Staphylococcus aureus Supplemental Surveiallance Officer Survey HAIC Multi-Site Gram-Negative Bacilli Case Report Form (MuGSI-CRE/CRAB) 0920-0978 2022 Carbapenem Resistant Enterobacteriaceae (CRE)/ Carbapenem resistant A. baumannii (CRAB) MuGSI HAIC Case Report Form HAIC Multi-Site Gram-Negative Surveillance Initiative - Extended Spectrum Beta-Lactamase Producing Enterobacteriaceae (MuGSI-ESBL) 0920-0978 2022 MuGSI Extended-Spectrum Beta-Lactamase (ESBL)-Producing Enterobacteriaceae Case Report Form HAIC Multi-site Gram-negative Surveillance Initiative (MuGSI) Supplemental Surveillance Officer Survey 0920-0978 MuGSI SO Survey Questionnaire Influenza Hospitalization Surveilance Network Case Report Form none Influenza Hospitalization Surveillance Network Case Report Influenza Hospitalization Surveillance Project Provider Vaccination History Fax Form (Children/Adults) 0920-0978 FluSurv Net Provider Vaccination History Fax Form Influenza Hospitalization Surveillance Project Vaccination Telephone Script / Consent Form (English) 0920-0978 FluSurv NET Vaccination Phone Script Influenza Hospitalization Surveillance Project Vaccination Telephone Script / Consent Form (Spanish) 0920-0978 FluSurv NET Vaccination Phone Script

---

ICR Summary of Burden

	Total Request	Previously Approved	Change Due to New Statute	Change Due to Agency Discretion	Change Due to Adjustment in Estimate	Change Due to Potential Violation of the PRA
Annual Number of Responses	132,520	99,360	0	33,160	0	0
Annual Time Burden (Hours)	53,784	38,810	0	14,974	0	0
Annual Cost Burden (Dollars)	0	0	0	0	0	0

Burden increases because of Program Change due to Agency Discretion: Yes

Burden Increase Due to: Miscellaneous Actions

Burden decreases because of Program Change due to Agency Discretion: Yes

Burden Reduction Due to: Miscellaneous Actions

Short Statement: Three new forms were added and a couple minor adjustments/corrections to burden or respondents.

---

Annual Cost to Federal Government: $36,032,895

Does this IC contain surveys, censuses, or employ statistical methods? Yes Part B of Supporting Statement

Does this ICR request any personally identifiable information (see OMB Circular No. A-130 for an explanation of this term)? Please consult with your agency's privacy program when making this determination.     Yes

Does this ICR include a form that requires a Privacy Act Statement (see 5 U.S.C. §552a(e)(3))? Please consult with your agency's privacy program when making this determination.     No

Is this ICR related to the Affordable Care Act [Pub. L. 111-148 & 111-152]? No

Is this ICR related to the Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]? No

Is this ICR related to the American Recovery and Reinvestment Act of 2009 (ARRA)? No

Is this ICR related to the Pandemic Response? No

Agency Contact: Kevin Joyce 404 639-1944 [email protected]

---

Common Form ICR:  No

---

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
		(a) It is necessary for the proper performance of agency functions;
		(b) It avoids unnecessary duplication;
		(c) It reduces burden on small entities;
		(d) It uses plain, coherent, and unambiguous language that is understandable to respondents;
		(e) Its implementation will be consistent and compatible with current reporting and recordkeeping practices;
		(f) It indicates the retention periods for recordkeeping requirements;
		(g) It informs respondents of the information called for under 5 CFR 1320.8 (b)(3) about:
			(i) Why the information is being collected;
			(ii) Use of information;
			(iii) Burden estimate;
			(iv) Nature of response (voluntary, required for a benefit, or mandatory);
			(v) Nature and extent of confidentiality; and
			(vi) Need to display currently valid OMB control number;
		(h) It was developed by an office that has planned and allocated resources for the efficient and effective management and use of the information to be collected.
		(i) It uses effective and efficient statistical survey methodology (if applicable); and
		(j) It makes appropriate use of information technology.
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
Certification Date: 04/25/2022

---